Skip to content
NovAccess Global Logo
XSNX 0.00 0.00 0.00%
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
NovAccess Global Logo
XSNX 0.00 0.00 0.00%
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact

Category: NovAccess Global Press Releases

Innovest Global Biotech Partners with Preeminent Los Angeles Association

Innovest Global Announces Elite Biotech Team

Innovest Global Biotech Division Sets Fall Conference Schedule

Innovest Global Biotech Division Sets Fall Conference Schedule

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

StemVax Obtains the Exclusive Worldwide Rights to Four Key Technologies

Innovest Global Announces Patent is Approved for StemVax Therapeutics

Innovest Global Acquires Stake in StemVax Therapeutics| Innovest Global

Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company

← older
newer →

Revolutionary advances in the  understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Youtube Facebook Twitter Linkedin

Privacy Policy

Forward-Looking Statements

Contact Us

  • info@novaccessglobal.com
  • Corporate HQ
  • 459 Columbus Ave. #607
    New York, NY 10025
  • Research & Development
  • 2265 E. Foothill Blvd, Pasadena, CA 91107

JOIN US

Stay up-to-date with our journey

Facebook Twitter Linkedin

Privacy Policy

Privacy Policy

Forward-Looking Statements